Romania's Antitrust Watchdog Fines Boehringer Ingelheim RCV RON128M For Abuse Of Dominant Position
<img src="http://storage0.dms.mpinteractiv.ro/media/401/1561/19649/22646383/1/download.jpg?width=160&height=120"/> Romania's Competition Council has fined Boehringer Ingelheim RCV GmbH & Co KG (Austria) a total RON128.47 million (EUR25.81 million) for abusing its dominant position in Romania’s market for medicines treating chronic obstructive pulmonary disease (COPD).

														<br/><br/><a href="https://core.adservingfactory.com/click?spgid=0&__x1ts=&pub=62&site=4268&section=0&zone=2008&size=0x0&__x1cguid=121">
					<img src="https://core.adservingfactory.com/ad?__x1ns=1&spgid=0&pub=632203491294404&site=rss.zf&section=site&zone=RSS_feed&size=300x250&__x1cguid=121" border="0" alt=""/>
					</a>